The current status of laparoscopic retroperitoneal lymph node dissection for non-seminomatous germ-cell tumors
Authors:
- 1 July 2005
- journal article
- review article
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 2 (7) , 330-335
Abstract
Retroperitoneal lymph node dissection (RPLND) is used in both the staging and management of non-seminomatous germ-cell tumors. Although a number of advantages of the laparoscopic approach have been reported over open RPLND, its use has not been supported by formal internal review board-approved studies. Brett Carver and Joel Sheinfeld discuss RPLND in the management of these tumors, both before and after chemotherapy. An appropriately performed retroperitoneal lymph node dissection (RPLND) is both a diagnostic and a therapeutic procedure in the management of non-seminomatous germ-cell tumors. In an attempt to minimize the morbidity associated with an open RPLND, several investigators have evaluated the role of laparoscopic RPLND. Laparoscopic RPLND is technically feasible in the hands of dedicated experts, and results in a reduced hospital stay, operative blood loss, and post-operative morbidity compared to open RPLND. Currently, however, none of the reports in the literature have adequately evaluated the therapeutic efficacy of laparoscopic RPLND, as the vast majority of patients are treated with adjuvant chemotherapy regardless of the risk of systemic relapse. Future prospective internal review board-approved trials need to be developed to evaluate the therapeutic efficacy of laparoscopic RPLND, with careful observation of patients with pathologic low-volume nodal disease.Keywords
This publication has 33 references indexed in Scilit:
- Incidence and Clinical Outcome of Patients with Teratoma in the Retroperitoneum Following Primary Retroperitoneal Lymph Node Dissection for Clinical Stages I and IIA Nonseminomatous Germ Cell TumorsJournal of Urology, 2003
- Results of Retroperitoneal Lymph Node Dissection for Clinical Stage I and II Pure Embryonal Carcinoma of the TestisJournal of Urology, 2003
- Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular CancerJournal of Clinical Oncology, 2003
- EXTRAPERITONEAL LAPAROSCOPIC PARA-AORTIC LYMPH NODE DISSECTION FOR EARLY STAGE NONSEMINOMATOUS GERM CELL TUMORS OF THE TESTIS WITH INTRODUCTION OF A NERVE SPARING TECHNIQUE: DESCRIPTION AND RESULTSJournal of Urology, 2001
- RISK OF SYSTEMIC METASTASES IN CLINICAL STAGE I NONSEMINOMA GERM CELL TESTIS TUMOR MANAGED BY RETROPERITONEAL LYMPH NODE DISSECTIONJournal of Urology, 2000
- Long–Term Experience with Laparoscopic Retroperitoneal Lymph Node Dissection in the Management of Low–Stage Testis CancerEuropean Urology, 2000
- Retroperitoneal Lymphadenectomy for Clinical Stage I Nonseminomatous Testicular Tumor: Laparoscopy Versus Open Surgery and Impact of Learning CurveJournal of Urology, 1996
- Teratoma in the Orchiectomy Specimen and Volume of Metastasis are Predictors of Retroperitoneal Teratoma in Low Stage Nonseminomatous Testis CancerJournal of Urology, 1996
- Late Relapse of Clinical Stage I Testicular CancerJournal of Urology, 1995
- Immediate Adjuvant Chemotherapy versus Observation with Treatment at Relapse in Pathological Stage II Testicular CancerNew England Journal of Medicine, 1987